• United Therapeutics average ebitda margin for 2023 was 52.84%, a 1.73% decline from 2022.
• United Therapeutics average ebitda margin for 2022 was 53.77%, a 72.51% decline from 2021.
• United Therapeutics average ebitda margin for 2021 was 31.17%, a 30.11% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.